Bricklaying ceremony marks major milestone for the expansion of Sheffield Institute for Translational Neuroscience (SITraN) ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Muscle stiffness, or rigidity, is another common early sign. It can happen in the arms, legs, or body and may feel like ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.

Guangdong Zhongsheng Ruichuang Pharmaceutical Co. Ltd. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, ...

A new study from Stanford Medicine has found that stopping an overactive enzyme in the brain might help protect and even ...